Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism
Open Access
- 1 October 2002
- journal article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 36 (4) , 913-917
- https://doi.org/10.1053/jhep.2002.35534
Abstract
Liver disease in patients with cystic fibrosis (CF) is inconstant and has not yet been clearly related to any specific risk factor. While the expression of cystic fibrosis transmembrane conductance regulator (CFTR) is restricted to the biliary epithelium in the liver, recent findings indicate that CFTR modulates reduced glutathione (GSH) transport and that CFTR dysfunction creates an imbalance in the antioxidant defense. Among liver detoxifying enzymes, the glutathione S-transferases (GSTs) play a key role in the protection against oxidative stress. Because oxidative injury contributes to the development of liver disease, we hypothesized that 2 members of the GST superfamily, GSTM1 and GSTP1, which are expressed in the biliary epithelium, could influence the hepatic status in patients with CF. The potential impact of GSTM1 and GSTP1 gene polymorphisms was assessed in 106 children with CF (mean age, 11.5 years). Based on polymerase chain reaction/restriction fragment length polymorphism analysis, we found that the frequency of GSTP1-Ile105/Ile105 genotype was significantly higher in patients with CF with liver disease than in those without (P < .03). Among the youngest patients, aged 6 years, GSTP1-Ile105/Ile105 genotype was associated with a 8-fold increase in the risk of liver disease compared with other GSTP1 genotypes (P = .002). No association between the GSTM1 genotype and liver status was documented. In conclusion, GSTP1-Ile105-encoding allele contributes to hepatic dysfunction in CF. Identification of this polymorphism may have prognostic value and prompt early treatment in patients with CF with an increased risk of liver disease.Keywords
Funding Information
- Institut National de la Santé et de la Recherche Médicale
- Assistance publique-Hôpitaux de Paris
- Association Vaincre la Mucoviscidose, Université de Paris
- Fondation pour la Recherche Médicale
- North Staffordshire Respiratory Research Foundation
This publication has 25 references indexed in Scilit:
- Correction of CFTR malfunction and stimulation of Ca2+-activated Cl− channels restore HCO3 − secretion in cystic fibrosis bile ductular cellsHepatology, 2002
- The mannose binding lectin gene influences the severity of chronic liver disease in cystic fibrosisJournal of Medical Genetics, 2001
- Phase I and Phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epitheliumHepatology, 1999
- Activation of rat hepatic stellate cells leads to loss of glutathion S -transferases and their enzymatic activity against products of oxidative stressHepatology, 1999
- Expression of Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator Protein and Related Chloride Transport Properties in the Gallbladder Epithelium From Cystic Fibrosis PatientsHepatology, 1999
- Identification of Glutathione S–Transferase Isozymes and γ–Glutamylcysteine Synthetase As Negative Acute–Phase Proteins in Rat LiverHepatology, 1998
- Oxidative Stress in the Liver and Biliary Tract DiseasesScandinavian Journal of Gastroenterology, 1998
- The plasma membrane polarity of human biliary epithelial cells: in situ immunohistochemical analysis and functional implicationsJournal of Hepatology, 1997
- Analysis of risk factors for the development of liver disease associated with cystic fibrosisThe Journal of Pediatrics, 1994
- Morphological findings in the liver of children with cystic fibrosis: A light and electron microscopical studyHepatology, 1986